Pulmonary Embolism: An Update Based on the Revised AWMF-S2k Guideline

 

 Permissions and Reprints

Abstract

Pulmonary embolism (PE) is the third most common acute cardiovascular disease. The risk of PE increases with age and mortality is high. Patients are stratified into hemodynamically stable versus unstable patients, as this has important implications for diagnosis and therapy. Since clinical signs and symptoms of acute PE are nonspecific, the clinical likelihood of PE is estimated to guide diagnostic pathways. D-dimer testing is performed in hemodynamically stable patients with low or intermediate probability of PE and the visualization of thromboembolism and its sequelae is commonly achieved with computed tomography pulmonary angiography (CTPA), supplemented by ultrasound techniques. With confirmed PE, another risk stratification estimates disease severity and defines intensity and setting of the ensuing treatment. The therapeutic spectrum ranges from outpatient treatment with initial oral anticoagulation to thrombolytic or interventional treatment in the intensive care unit or catheterization laboratory. In single cases, even acute surgical thrombectomy is attempted.

Publication History

Received: 17 September 2023

Accepted: 14 December 2023

Article published online:
30 April 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res 2016; 118 (09) 1340-1347
  CrossrefPubMedGoogle Scholar
• 2 Barco S, Valerio L, Ageno W. et al. Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database. Lancet Respir Med 2021; 9 (01) 33-42
  CrossrefPubMedGoogle Scholar
• 3 Cohen AT, Agnelli G, Anderson FA. et al; VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98 (04) 756-764
  PubMedGoogle Scholar
• 4 Keller K, Hobohm L, Ebner M. et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur Heart J 2020; 41 (04) 522-529
  CrossrefPubMedGoogle Scholar
• 5 Hobohm L, Keller K, Konstantinides S. Pulmonary embolism. Inn Med (Heidelb) 2023; 64 (01) 40-49
  PubMedGoogle Scholar
• 6 Pollack CV, Schreiber D, Goldhaber SZ. et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J Am Coll Cardiol 2011; 57 (06) 700-706
  CrossrefPubMedGoogle Scholar
• 7 Wells PS, Ginsberg JS, Anderson DR. et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med 1998; 129 (12) 997-1005
  CrossrefPubMedGoogle Scholar
• 8 Le Gal G, Righini M, Roy PM. et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med 2006; 144 (03) 165-171
  CrossrefPubMedGoogle Scholar
• 9 Klok FA, Mos IC, Nijkeuter M. et al. Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism. Arch Intern Med 2008; 168 (19) 2131-2136
  CrossrefPubMedGoogle Scholar
• 10 Weitz JI, Fredenburgh JC, Eikelboom JW. A test in context: D-dimer. J Am Coll Cardiol 2017; 70 (19) 2411-2420
  CrossrefPubMedGoogle Scholar
• 11 Konstantinides SV, Meyer G, Becattini C. et al; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020; 41 (04) 543-603
  CrossrefPubMedGoogle Scholar
• 12 Patel P, Patel P, Bhatt M. et al. Systematic review and meta-analysis of test accuracy for the diagnosis of suspected pulmonary embolism. Blood Adv 2020; 4 (18) 4296-4311
  CrossrefPubMedGoogle Scholar
• 13 Remy-Jardin M, Ryerson CJ, Schiebler ML. et al. Imaging of pulmonary hypertension in adults: a position paper from the Fleischner Society. Eur Respir J 2021; 57 (01) 2004455
  CrossrefPubMedGoogle Scholar
• 14 Fields JM, Davis J, Girson L. et al. Transthoracic echocardiography for diagnosing pulmonary embolism: a systematic review and meta-analysis. J Am Soc Echocardiogr 2017; 30 (07) 714-723.e4
  CrossrefPubMedGoogle Scholar
• 15 Daley JI, Dwyer KH, Grunwald Z. et al. Increased sensitivity of focused cardiac ultrasound for pulmonary embolism in emergency department patients with abnormal vital signs. Acad Emerg Med 2019; 26 (11) 1211-1220
  CrossrefPubMedGoogle Scholar
• 16 Patel B, Shah M, Garg L, Agarwal M, Martinez M, Dusaj R. Trends in the use of echocardiography in pulmonary embolism. Medicine (Baltimore) 2018; 97 (35) e12104
  CrossrefPubMedGoogle Scholar
• 17 Alerhand S, Sundaram T, Gottlieb M. What are the echocardiographic findings of acute right ventricular strain that suggest pulmonary embolism?. Anaesth Crit Care Pain Med 2021; 40 (02) 100852
  CrossrefPubMedGoogle Scholar
• 18 Lang RM, Badano LP, Mor-Avi V. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28 (01) 1-39.e14
  CrossrefPubMedGoogle Scholar
• 19 Volpicelli G, Elbarbary M, Blaivas M. et al; International Liaison Committee on Lung Ultrasound (ILC-LUS) for International Consensus Conference on Lung Ultrasound (ICC-LUS). International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med 2012; 38 (04) 577-591
  CrossrefPubMedGoogle Scholar
• 20 Chen W, Xu K, Li Y. et al. Clinical value of thoracic ultrasonography in the diagnosis of pulmonary embolism: a systematic review and meta-analysis. Med Ultrason 2022; 24 (02) 226-234
  CrossrefPubMedGoogle Scholar
• 21 Zhu R, Ma XC. Clinical value of ultrasonography in diagnosis of pulmonary embolism in critically ill patients. J Transl Int Med 2017; 5 (04) 200-204
  CrossrefPubMedGoogle Scholar
• 22 Germini F, Zarabi S, Eventov M, Turcotte M, Li M, de Wit K. Pulmonary embolism prevalence among emergency department cohorts: a systematic review and meta-analysis by country of study. J Thromb Haemost 2021; 19 (01) 173-185
  CrossrefPubMedGoogle Scholar
• 23 Jaureguízar A, Jiménez D, Bikdeli B. et al; Registro Informatizado de la Enfermedad TromboEmbólica Investigators. Heart rate and mortality in patients with acute symptomatic pulmonary embolism. Chest 2022; 161 (02) 524-534
  CrossrefPubMedGoogle Scholar
• 24 Linnemann BBW, Doenst T, Erbel C. et al. Diagnostics and Therapy of Venous Thrombosis and Pulmonary Embolism. The revised AWMF S2k Guideline. Vasa 2023; Oct; 52 (S111): 1-146 PMID: 37904504. DOI: 10.1024/0301-1526/a001089
  CrossrefPubMedGoogle Scholar
• 25 Jiménez D, Aujesky D, Moores L. et al; RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010; 170 (15) 1383-1389
  CrossrefPubMedGoogle Scholar
• 26 Stevens SM, Woller SC, Baumann Kreuziger L. et al. Executive summary: antithrombotic therapy for VTE disease—second update of the CHEST Guideline and Expert Panel Report. Chest 2021; 160 (06) 2247-2259
  CrossrefPubMedGoogle Scholar
• 27 Barco S, Mahmoudpour SH, Planquette B, Sanchez O, Konstantinides SV, Meyer G. Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systematic review and meta-analysis. Eur Heart J 2019; 40 (11) 902-910
  CrossrefPubMedGoogle Scholar
• 28 Becattini C, Agnelli G, Lankeit M. et al. Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model. Eur Respir J 2016; 48 (03) 780-786
  CrossrefPubMedGoogle Scholar
• 29 Klok FA, Ageno W, Ay C. et al. Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society. Eur Heart J 2022; 43 (03) 183-189
  CrossrefPubMedGoogle Scholar
• 30 Ghanem A, Andrassy M, Dürschmied D. et al. Interventionelle Therapie und multidisziplinäre Managementstrategien für die akute Lungenembolie. Kardiologe 2023; 17 (03) 141-159
  CrossrefPubMedGoogle Scholar
• 31 Hobohm L, Farmakis IT, Keller K. et al. Pulmonary embolism response team (PERT) implementation and its clinical value across countries: a scoping review and meta-analysis. Clin Res Cardiol 2023; 112 (10) 1351-1361
  CrossrefPubMedGoogle Scholar
• 32 !!! INVALID CITATION !!! {}
  PubMed
• 33 Khosla A, Mojibian H, Assi R, Tantawy H, Singh I, Pollak J. Right heart thrombi (RHT) and clot in transit with concomitant PE management: approach and considerations. Pulm Circ 2022; 12 (02) e12080
  CrossrefPubMedGoogle Scholar
• 34 Quezada CA, Bikdeli B, Barrios D. et al. Meta-analysis of prevalence and short-term prognosis of hemodynamically unstable patients with symptomatic acute pulmonary embolism. Am J Cardiol 2019; 123 (04) 684-689
  CrossrefPubMedGoogle Scholar
• 35 Murin S, Romano PS, White RH. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thromb Haemost 2002; 88 (03) 407-414
  Article in Thieme ConnectPubMedGoogle Scholar
• 36 Mearns ES, Coleman CI, Patel D. et al. Index clinical manifestation of venous thromboembolism predicts early recurrence type and frequency: a meta-analysis of randomized controlled trials. J Thromb Haemost 2015; 13 (06) 1043-1052
  CrossrefPubMedGoogle Scholar
• 37 Zuo Z, Yue J, Dong BR, Wu T, Liu GJ, Hao Q. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst Rev 2021; 4 (04) CD004437
  PubMedGoogle Scholar
• 38 Barilli M, Tavera MC, Valente S, Palazzuoli A. Structural and hemodynamic changes of the right ventricle in PH-HFpEF. Int J Mol Sci 2022; 23 (09) 4554
  CrossrefPubMedGoogle Scholar
• 39 Sanchez O, Charles-Nelson A, Ageno W. et al; PEITHO-3 Investigators. Reduced-dose intravenous thrombolysis for acute intermediate-high-risk pulmonary embolism: rationale and design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial. Thromb Haemost 2022; 122 (05) 857-866
  Article in Thieme ConnectPubMedGoogle Scholar
• 40 Zhang Z, Zhai ZG, Liang LR, Liu FF, Yang YH, Wang C. Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis. Thromb Res 2014; 133 (03) 357-363
  CrossrefPubMedGoogle Scholar
• 41 Pruszczyk P, Klok FA, Kucher N. et al. Percutaneous treatment options for acute pulmonary embolism: a clinical consensus statement by the ESC working group on pulmonary circulation and right ventricular function and the European Association of Percutaneous Cardiovascular Interventions. EuroIntervention 2022; 18 (08) e623-e638
  CrossrefPubMedGoogle Scholar
• 42 Götzinger F, Lauder L, Sharp ASP. et al. Interventional therapies for pulmonary embolism. Nat Rev Cardiol 2023; 20 (10) 670-684
  CrossrefPubMedGoogle Scholar
• 43 Zieliński D, Dyk W, Wróbel K, Biederman A. Surgical pulmonary embolectomy: state of the art. Kardiochir Torakochirurgia Pol 2023; 20 (02) 111-117
  PubMedGoogle Scholar
• 44 Loyalka P, Ansari MZ, Cheema FH, Miller III CC, Rajagopal S, Rajagopal K. Surgical pulmonary embolectomy and catheter-based therapies for acute pulmonary embolism: a contemporary systematic review. J Thorac Cardiovasc Surg 2018; 156 (06) 2155-2167
  CrossrefPubMedGoogle Scholar